Stocks
Cancer care's next chapter
Big pharma is eyeing the future.
Follow pharmaceutical company stocks—blockbuster drugs, patent cliffs, pipeline depth, and pricing policy risks affecting pharma valuations.
Big pharma is eyeing the future.
Eli wins this round, while Novo continues to flounder.
Shares sank on the news.
The two pharma companies are duking it out for the future of weight-loss drugs.
Both pharma giants are working to create new obesity pills.
Martin Shkreli is shorting a pharmaceutical company, and people are listening to him for some reason.
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.